BioLASCO Taiwan Market Cap

BioLASCO Taiwan has a market cap or net worth of 845.20 million as of May 2, 2025. Its market cap has decreased by -12.35% in one year.

Market Cap

845.20M

Enterprise Value

789.69M

Revenue

292.50M

Ranking

n/a

PE Ratio

19.20

Stock Price

33.00

Market Cap Chart

Since January 4, 2018, BioLASCO Taiwan's market cap has decreased from 1.58B to 845.20M, a decrease of -46.54%. That is a compound annual growth rate of -8.20%.

Market Cap History

Date	Market Cap	% Change
Apr 30, 2025	854.16M	0.76%
Dec 31, 2024	847.76M	-0.30%
Dec 29, 2023	850.32M	11.22%
Dec 30, 2022	764.52M	-1.97%
Dec 30, 2021	779.89M	-13.74%
Dec 31, 2020	904.10M	-7.47%
Dec 31, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
PharmaEssentia	174.85B
Caliway Biopharmaceuticals	103.28B
Bora Pharmaceuticals Co., LTD.	73.22B
Lotus Pharmaceutical	57.54B
Oneness Biotech	29.88B
Polaris Group	28.35B
Lumosa Therapeutics	27.61B
Pegavision	27.14B

Market Cap Rankings